Vibrex 40mg Tablet
By Vibrex
Rx
10 Tablet in a Strip

Composition
Vilazodone(40mg)

Manufacturer - Strides shasun Ltd
Strides Shasun Limited, (Formerly Strides Arcolab Limited), Strides House, Bilekahalli, Bannerghatta Road, Bangalore – 560076, India

Expires on or after
July, 2025

liver
Vibrex 40mg Tablet should be used with caution in individuals with severe liver disease. In such cases, dose adjustment of Vibrex 40mg Tablet may be necessary. It is important to seek advice from your healthcare provider before using this medication. Limited information is available about the use of Vibrex 40mg Tablet in patients with severe liver disease. However, no dose adjustment is recommended for individuals with mild to moderate liver disease. If you have any concerns regarding the use of Vibrex 40mg Tablet and its potential effects on your liver health, consult your doctor for personalized guidance.

kidney
Vibrex 40mg Tablet is generally considered safe for use in patients with kidney disease. However, caution is advised for individuals with severe kidney diseases as the dosage may need adjustment. Always consult your doctor regarding your specific condition.

alcohol
Caution is advised against consuming alcohol while taking Vibrex 40mg Tablet as it can interact with the medication and raise the chances of experiencing side effects. It is recommended to consult your doctor for guidance.

driving
Vibrex 40mg Tablet may reduce alertness and cause drowsiness, affecting vision and coordination. Avoid driving if experiencing these effects to ensure safety on the road. Similarly, refrain from operating heavy machinery due to the potential impact on alertness.

pregnancy
Vibrex 40mg Tablet may not be safe during pregnancy. Limited studies in humans suggest potential harm to the developing baby. Consult your doctor for careful consideration of benefits and risks before using during pregnancy. Use in pregnant women only if clearly needed and benefits surpass risks.

breastfeeding
Vibrex 40mg Tablet may not be safe during breastfeeding as it can pass into breastmilk and harm the baby. Use only if clinically necessary and benefits outweigh risks.
Habit Forming | No |
Chemical Class | N-Arylpiperazines Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Serotonin partial agonist reuptake inhibitor (SPARI) |
₹325
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024